Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF407 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-10 |
mRNA | ZNF8 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | NCKAP1L | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-06 |
mRNA | ADNP2 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-11 |
mRNA | GMFG | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-06 |
mRNA | TFAP4 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | WAS | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0004 |
mRNA | MBTD1 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-09 |
mRNA | WRN | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
mRNA | ZNF766 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |